184 related articles for article (PubMed ID: 16611324)
1. Transplant tolerance in non-human primates: progress, current challenges and unmet needs.
Kean LS; Gangappa S; Pearson TC; Larsen CP
Am J Transplant; 2006 May; 6(5 Pt 1):884-93. PubMed ID: 16611324
[TBL] [Abstract][Full Text] [Related]
2. Primate models in organ transplantation.
Anderson DJ; Kirk AD
Cold Spring Harb Perspect Med; 2013 Sep; 3(9):a015503. PubMed ID: 24003248
[TBL] [Abstract][Full Text] [Related]
3. Transplant Tolerance: Current Insights and Strategies for Long-Term Survival of Xenografts.
Liu L; He C; Liu J; Lv Z; Wang G; Gao H; Dai Y; Cooper DKC; Cai Z; Mou L
Arch Immunol Ther Exp (Warsz); 2018 Oct; 66(5):355-364. PubMed ID: 29992337
[TBL] [Abstract][Full Text] [Related]
4. Preclinical and clinical studies on the induction of renal allograft tolerance through transient mixed chimerism.
Kawai T; Cosimi AB; Sachs DH
Curr Opin Organ Transplant; 2011 Aug; 16(4):366-71. PubMed ID: 21666482
[TBL] [Abstract][Full Text] [Related]
5. Nonhuman primate models of transplant tolerance: closer to the holy grail.
Kitchens WH; Adams AB
Curr Opin Organ Transplant; 2016 Feb; 21(1):59-65. PubMed ID: 26709576
[TBL] [Abstract][Full Text] [Related]
6. Mixed chimerism through donor bone marrow transplantation: a tolerogenic cell therapy for application in organ transplantation.
Pilat N; Hock K; Wekerle T
Curr Opin Organ Transplant; 2012 Feb; 17(1):63-70. PubMed ID: 22186093
[TBL] [Abstract][Full Text] [Related]
7. Intra-bone Bone Marrow Transplantation in Pig-to-Nonhuman Primates for the Induction of Tolerance Across Xenogeneic Barriers.
Yamada K; Ariyoshi Y; Pomposelli T; Takeuchi K
Methods Mol Biol; 2020; 2110():213-225. PubMed ID: 32002911
[TBL] [Abstract][Full Text] [Related]
8. Clinical strategy for induction of transplantation tolerance through mixed chimerism.
Cosimi AB; Sachs DH; Sykes M; Kawai T
Clin Transpl; 2013; ():127-34. PubMed ID: 25095501
[TBL] [Abstract][Full Text] [Related]
9. A cure for murine sickle cell disease through stable mixed chimerism and tolerance induction after nonmyeloablative conditioning and major histocompatibility complex-mismatched bone marrow transplantation.
Kean LS; Durham MM; Adams AB; Hsu LL; Perry JR; Dillehay D; Pearson TC; Waller EK; Larsen CP; Archer DR
Blood; 2002 Mar; 99(5):1840-9. PubMed ID: 11861303
[TBL] [Abstract][Full Text] [Related]
10. Facilitating cells as a venue to establish mixed chimerism and tolerance.
Jacquet EG; Schanie CL; Fugier-Vivier I; Willer SS; Ildstad ST
Pediatr Transplant; 2003 Oct; 7(5):348-57. PubMed ID: 14738294
[TBL] [Abstract][Full Text] [Related]
11. The Knife's Edge of Tolerance: Inducing Stable Multilineage Mixed Chimerism but With a Significant Risk of CMV Reactivation and Disease in Rhesus Macaques.
Zheng HB; Watkins B; Tkachev V; Yu S; Tran D; Furlan S; Zeleski K; Singh K; Hamby K; Hotchkiss C; Lane J; Gumber S; Adams AB; Cendales L; Kirk AD; Kaur A; Blazar BR; Larsen CP; Kean LS
Am J Transplant; 2017 Mar; 17(3):657-670. PubMed ID: 27500470
[TBL] [Abstract][Full Text] [Related]
12. Treatment with immunotoxin.
Knechtle SJ
Philos Trans R Soc Lond B Biol Sci; 2001 May; 356(1409):681-9. PubMed ID: 11375071
[TBL] [Abstract][Full Text] [Related]
13. Immunosenescence does not abrogate engraftment of murine allogeneic bone marrow.
Hock K; Oberhuber R; Lee YL; Wrba F; Wekerle T; Tullius SG
Transplantation; 2013 Jun; 95(12):1431-8. PubMed ID: 23694950
[TBL] [Abstract][Full Text] [Related]
14. Induction of Major Histocompatibility Complex-mismatched Mouse Lung Allograft Acceptance With Combined Donor Bone Marrow: Lung Transplant Using a 12-Hour Nonmyeloablative Conditioning Regimen.
Dodd-O JM; Ganguly S; Vulic A; Panoskaltsis-Mortari A; McDyer JF; Luznik L
Transplantation; 2016 Dec; 100(12):e140-e146. PubMed ID: 27861294
[TBL] [Abstract][Full Text] [Related]
15. Tolerance through bone marrow transplantation with costimulation blockade.
Wekerle T; Blaha P; Langer F; Schmid M; Muehlbacher F
Transpl Immunol; 2002 May; 9(2-4):125-33. PubMed ID: 12180819
[TBL] [Abstract][Full Text] [Related]
16. Induction of stable long-term mixed hematopoietic chimerism following nonmyeloablative conditioning with T cell-depleting antibodies, cyclophosphamide, and thymic irradiation leads to donor-specific in vitro and in vivo tolerance.
Mapara MY; Pelot M; Zhao G; Swenson K; Pearson D; Sykes M
Biol Blood Marrow Transplant; 2001; 7(12):646-55. PubMed ID: 11787527
[TBL] [Abstract][Full Text] [Related]
17. An MHC-defined primate model reveals significant rejection of bone marrow after mixed chimerism induction despite full MHC matching.
Larsen CP; Page A; Linzie KH; Russell M; Deane T; Stempora L; Strobert E; Penedo MC; Ward T; Wiseman R; O'Connor D; Miller W; Sen S; Singh K; Kean LS
Am J Transplant; 2010 Nov; 10(11):2396-409. PubMed ID: 20849552
[TBL] [Abstract][Full Text] [Related]
18. Knowledge about transplantation tolerance gained in primates.
Knechtle SJ
Curr Opin Immunol; 2000 Oct; 12(5):552-6. PubMed ID: 11007358
[TBL] [Abstract][Full Text] [Related]
19. Development of tolerogenic strategies in the clinic.
Knechtle SJ
Philos Trans R Soc Lond B Biol Sci; 2005 Sep; 360(1461):1739-46. PubMed ID: 16147538
[TBL] [Abstract][Full Text] [Related]
20. Overcoming memory T-cell responses for induction of delayed tolerance in nonhuman primates.
Yamada Y; Boskovic S; Aoyama A; Murakami T; Putheti P; Smith RN; Ochiai T; Nadazdin O; Koyama I; Boenisch O; Najafian N; Bhasin MK; Colvin RB; Madsen JC; Strom TB; Sachs DH; Benichou G; Cosimi AB; Kawai T
Am J Transplant; 2012 Feb; 12(2):330-40. PubMed ID: 22053723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
